Australia's largest stock trading and investment forum Australia's #1 stock forum

NEA

Click for more information

0.00%

$2.10 nearmap ltd

Nearmap slides as Macquarie cuts outlook, page-65

First 65 Last

Share
Profile

Follow
BellGuide3124

878 Posts.

45

22/02/22

11:22

Post #: 59727710
Share

Originally posted by Pomodoro: ↑

Nearmap slides as Macquarie cuts outlook

MATT BELLMacquarie downgrades Nearmap to underperform and slashes target price to $1.30 as the aerial mapping business faces increasing competition in Australia and New Zealand.The broker says Nearmap, which is trading at a premium to other listed aerial imaging peers, is likely to see its market share at home fall as new players enter the market and it faces litigation risk overseas."We forecast growth to moderate in ANZ from more competition, whilst in North America Nearmap will continue to gain market share, but this will result in higher OPEX," the broker says.Macquarie says those assumptions drive its FY22-24 revenue, and EBITDA forecasts, which are up to 34 per cent below consensus. Its revenue estimates for that period have slightly changed, while EBITDA is revised down by 41 per cent.The $1.30 target price is based on an enterprise value multiple of 20 times forecast EBITDA in FY23.Shares in Nearmap are 6.7 per cent lower to $1.29 at 3.18pm AEDT.

Expand

I don't like their complex accounting system and they always seems to be expanding into new areas which result in new expenses. Why can't they just concentrate growing in USA?

NEA Price at posting: $1.23 Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: US inflation hits 3%; local futures indicate fresh all-time-high | 12 July 2024

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

There are more pages in this discussion • 4 more messages in this thread...

First 65 Last

Add NEA (ASX) to my watchlist